Personal information

Verified email domains

melanoma, BRAFV600E isoforms, pigmentation, in vivo melanoma modeling, attenuated Listeria monocytogenes
Italy

Biography

In 2000, I graduated in Biological Sciences and in 2004 I got my PhD in Molecular Biotechnology, both at University of Pisa, Italy. In 2006, I moved to the US, where I became a post-doctoral fellow in the laboratory of Prof. Pier Paolo Pandolfi, first at MSKCC in New York and then at BIDMC-HMS in Boston. In 2009, I started a second post-doc in the lab of Prof. Iman Osman at NYU. In 2012, I was appointed as Principal Investigator of the Oncogenomics Unit of ITT (now ISPRO) and in 2016 I became Staff Scientist-Ricercatore at the Institute of Clinical Physiology of the National Research Council in Pisa, Italy, where my lab is located. In 2021, I became Senior Staff Scientist-Primo Ricercatore.
Throughout my scientific career, my research interests have mostly revolved around non-coding RNAs (microRNAs, pseudogenes, ceRNAs) in cancer. Currently, we study the coding and non-coding regulatory networks that revolve around BRAFV600E isoforms in melanoma, with the goal to better understand how this oncogene works, to hamper tolerance mechanisms, and to potentiate the efficacy of BRAF inhibitors. Specifically, we are interested in the regulation of isoform expression; the kinase-(in)dependent and coding-(in)dependent functions of each isoform, as well as its modulators, interactors and effectors. To do so, we take advantage of a wide range of techniques: in silico (omics approaches), in vitro (yeast, melanoma cell lines), in vivo (melanoma modeling in zebrafish and in the mouse), and ex vivo (melanoma specimens).
We are also developing new strategies for selective drug delivery, taking advantage of attenuated Listeria monocytogenes.

Activities

Employment (8)

Institute of Clinical Physiology-CNR: Pisa, IT

2021-01-01 to present | Senior Staff Scientist-Primo Ricercatore
Employment
Source: Self-asserted source
Laura Poliseno

ISPRO: Pisa, IT

2012-02-01 to present | Principal Investigator of the Oncogenomics Unit
Employment
Source: Self-asserted source
Laura Poliseno

Institute of Clinical Physiology-CNR: Pisa, IT

2016-12-30 to 2020-12-31 | Staff Scientist-Ricercatore
Employment
Source: Self-asserted source
Laura Poliseno

Azienda Ospedaliero-Universitaria Pisana: Pisa, IT

2012-02-01 to 2016-12-29 | Dirigente Biologo
Employment
Source: Self-asserted source
Laura Poliseno

New York University: New York, NY, US

2009-06-16 to 2011-10-20 | Post-Doctoral Research Fellow
Employment
Source: Self-asserted source
Laura Poliseno

Harvard Medical School: Boston, MA, US

2007-08-01 to 2009-06-15 | Post-Doctoral Research Fellow
Employment
Source: Self-asserted source
Laura Poliseno

Memorial Sloan Kettering Cancer Center: New York, NY, US

2006-01-02 to 2007-07-31 | Post-Doctoral Research Fellow
Employment
Source: Self-asserted source
Laura Poliseno

Scuola Normale Superiore: Pisa, IT

2004-06-01 to 2005-12-31 | Post-Doctoral Research Fellow
Employment
Source: Self-asserted source
Laura Poliseno

Education and qualifications (2)

University of Pisa: Pisa, IT

2004-03-29 | PhD in Molecular Biotechnologies
Education
Source: Self-asserted source
Laura Poliseno

University of Pisa: Pisa, IT

2000-04-12 | Master Degree in Biological Sciences cum laude
Education
Source: Self-asserted source
Laura Poliseno

Professional activities (9)

Zebrafish Disease Model Society: Clifton Park, New York, US

2022-08-01 to present | Member
Membership
Source: Self-asserted source
Laura Poliseno

European Association For Cancer Research: Nottingham, Nottingham, GB

2020-01-09 to present | Member (and Ambassador since September 14 2020)
Membership
Source: Self-asserted source
Laura Poliseno

CNR: Pisa, IT

2014-01-01 to present | Manager of the Zebrafish Facility (IFC)
Service
Source: Self-asserted source
Laura Poliseno

CNR: Pisa, IT

2013-01-01 to present | Manager of the Flow Cytometry Facility (IFC)
Service
Source: Self-asserted source
Laura Poliseno

Ministero dell'Università: Roma, IT

2023-06-09 | Abilitazione a Professore di Prima Fascia in Biologia Molecolare (05/E2)
Distinction
Source: Self-asserted source
Laura Poliseno

Ministero dell'Università: Roma, IT

2023-06-09 | Abilitazione a Professore di Prima Fascia in Biologia Applicata (05/F1)
Distinction
Source: Self-asserted source
Laura Poliseno

Ministero dell'Università: Roma, IT

2023-06-09 | Abilitazione a Professore di Prima Fascia in Genetica (05/I1)
Distinction
Source: Self-asserted source
Laura Poliseno

Ministero dell'Università: Roma, IT

2017-12-07 | Abilitazione a Professore di Prima Fascia in Biologia Molecolare (05/E2)
Distinction
Source: Self-asserted source
Laura Poliseno

Ministero dell'Università: Roma, IT

2017-08-01 | Abilitazione a Professore di Seconda Fascia in Genetica (05/I1)
Distinction
Source: Self-asserted source
Laura Poliseno

Funding (6)

BRAFV600E isoforms: the unknown unknown in melanoma biology

2024-05 to 2027-05 | Grant
Fondazione Pisa (Pisa, IT)
Source: Self-asserted source
Laura Poliseno

CN3-National Center for Gene Therapy and Drugs based on RNA Technology

2022-11 to 2025-10 | Grant
European Union-Next Generation EU (Brussels, BE)
Source: Self-asserted source
Laura Poliseno

The dark side of BRAFi: hampering pigmentation to boost the efficacy of targeted therapy in melanoma

2022-01 to 2026-12 | Grant
Associazione Italiana per la Ricerca sul Cancro (Milano, IT)
GRANT_NUMBER:

IG 25694

Source: Self-asserted source
Laura Poliseno

miR-204 inhibition and attenuated Listeria monocytogenes: development of a novel therapeutic strategy against melanoma

2016-01 to 2019-12 | Grant
Associazione Italiana per la Ricerca sul Cancro (Milano, IT)
GRANT_NUMBER:

MFAG 17095

Source: Self-asserted source
Laura Poliseno

Dissecting the molecular bases of acquired resistance to BRAF inhibitors in metastatic melanoma: towards a multidrug approach

2014-11 to 2018-11 | Grant
Ministero della Salute (Roma, IT)
GRANT_NUMBER:

GR-2011-02348535

Source: Self-asserted source
Laura Poliseno

Start Up and Institutional Funding

2012-02 to 2024-12 | Grant
ISPRO (Firenze, IT)
Source: Self-asserted source
Laura Poliseno

Works (50 of 79)

Items per page:
Page 1 of 2

PARP1 in Melanoma: Mechanistic Insights and Implications for Basic and Clinical Research

Cancer Letters
2025-02 | Journal article
Contributors: Andrea Marranci; Luisa Maresca; Samuele Lodovichi; Andrea Ghelli Luserna di Rorà; Barbara Stecca; Laura Poliseno
Source: check_circle
Crossref

The 2024 Nobel Prize in Physiology or Medicine: microRNA Takes Center Stage

Non-Coding RNA
2024-12-12 | Journal article
Contributors: George A. Calin; Florent Hubé; Michael R. Ladomery; Nicholas Delihas; Manuela Ferracin; Laura Poliseno; Luca Agnelli; Suresh K. Alahari; Ai-Ming Yu; Xiao-Bo Zhong
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Enhancing the Anticancer Activity of Attenuated <i>Listeria monocytogenes</i> by Cell Wall Functionalization with "Clickable" Doxorubicin.

ACS chemical biology
2024-09 | Journal article
Contributors: Lepori I; Roncetti M; Vitiello M; Barresi E; De Paolo R; Tentori PM; Baldanzi C; Santi M; Evangelista M; Signore G et al.
Source: Self-asserted source
Laura Poliseno via Europe PubMed Central

Coding, or non-coding, that is the question

Cell Research
2024-07-25 | Journal article
Contributors: Laura Poliseno; Martina Lanza; Pier Paolo Pandolfi
Source: check_circle
Crossref

Modified Cas9-Guided Oxford Nanopore Technology Sequencing Uncovers Single and Multiple Transgene Insertion Sites in a Zebrafish Melanoma Model

The CRISPR Journal
2023-12-01 | Journal article
Contributors: Raffaella De Paolo; Uday Munagala; Francesco Cucco; Samanta Sarti; Letizia Pitto; Filippo Martignano; Silvestro G. Conticello; Laura Poliseno
Source: check_circle
Crossref

Enhancing the anticancer activity of attenuated Listeria monocytogenes by cell wall functionalization with “clickable” doxorubicin

2023-09-22 | Preprint
Contributors: Laura Poliseno; Irene Lepori; Marta Roncetti; Marianna Vitiello; Elisabetta Barresi; Paolo Tentori; Caterina Baldanzi; Monica Evangelista; Giovanni Signore; Lorena Tedeschi et al.
Source: check_circle
Crossref

Differential impact of BRAFV600E isoforms on tumorigenesis in a zebrafish model of melanoma

Cell & Bioscience
2023-07-01 | Journal article
Contributors: Raffaella De Paolo; Samanta Sarti; Sara Bernardi; Francesco Cucco; Andrea Tavosanis; Letizia Pitto; Laura Poliseno
Source: check_circle
Crossref

A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAF<sup>V600E</sup> in cancer cells.

European journal of medicinal chemistry
2023-05 | Journal article
Contributors: Barresi E; Baldanzi C; Roncetti M; Roggia M; Baglini E; Lepori I; Vitiello M; Salerno S; Tedeschi L; Da Settimo F et al.
Source: Self-asserted source
Laura Poliseno via Europe PubMed Central

PARP1 negatively regulates MAPK signaling by impairing BRAF-X1 translation.

Journal of hematology & oncology
2023-04 | Journal article
Contributors: Marranci A; Prantera A; Masotti S; De Paolo R; Baldanzi C; Podda MS; Mero S; Vitiello M; Franchin C; Laezza M et al.
Source: Self-asserted source
Laura Poliseno via Europe PubMed Central

A Network of MicroRNAs and mRNAs Involved in Melanosome Maturation and Trafficking Defines the Lower Response of Pigmentable Melanoma Cells to Targeted Therapy.

Cancers
2023-01 | Journal article
Contributors: Vitiello M; Mercatanti A; Podda MS; Baldanzi C; Prantera A; Sarti S; Rizzo M; Salvetti A; Conte F; Fiscon G et al.
Source: Self-asserted source
Laura Poliseno via Europe PubMed Central

An Immunocompetent Environment Unravels the Proto-Oncogenic Role of miR-22

Cancers
2022-12-19 | Review | Author
Part of ISSN: 2072-6694
Contributors: Maria Laura Centomo; Marianna Vitiello; Laura Poliseno; Pier Paolo Pandolfi
Source: Self-asserted source
Laura Poliseno
grade
Preferred source (of 2)‎

Editorial: Role of pigmentation in melanoma

Frontiers in Oncology
2022-11-23 | Review
Part of ISSN: 2234-943X
Contributors: Anna A. Brożyna; Laura Poliseno; Andrzej T. Slominski
Source: Self-asserted source
Laura Poliseno

p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells

Journal of Biological Chemistry
2022-09 | Journal article
Contributors: Silvia Pietrobono; Raffaella De Paolo; Domenico Mangiameli; Andrea Marranci; Ilaria Battisti; Cinzia Franchin; Giorgio Arrigoni; Davide Melisi; Laura Poliseno; Barbara Stecca
Source: check_circle
Crossref

CRISPR/Cas Technologies Applied to Pseudogenes

Methods in Molecular Biology
2021 | Book chapter
Part of ISBN: 9781071615027
Part of ISBN: 9781071615034
Part of ISSN: 1064-3745
Part of ISSN: 1940-6029
Contributors: Marianna Vitiello; Laura Poliseno
Source: Self-asserted source
Laura Poliseno

High-Throughput Identification of miRNA–Target Interactions in Melanoma Using miR-CATCHv2.0

Methods in Molecular Biology
2021 | Book chapter
Part of ISBN: 9781071612040
Part of ISBN: 9781071612057
Part of ISSN: 1064-3745
Part of ISSN: 1940-6029
Contributors: Andrea Marranci; Romina D’Aurizio; Milena Rizzo; Catherine M. Greene; Laura Poliseno
Source: Self-asserted source
Laura Poliseno

In Vivo Silencing/Overexpression of lncRNAs by CRISPR/Cas System

Long Non-Coding RNAs in Cancer
2021 | Book chapter
Part of ISBN: 9781071615805
Part of ISBN: 9781071615812
Part of ISSN: 1064-3745
Part of ISSN: 1940-6029
Contributors: Marianna Vitiello; Laura Poliseno; Pier Paolo Pandolfi
Source: Self-asserted source
Laura Poliseno

Pseudogenes

Springer US
2021 | Book
Part of ISSN: 1064-3745
Part of ISSN: 1940-6029
Source: Self-asserted source
Laura Poliseno

GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma.

The British journal of dermatology
2021-10 | Journal article
Contributors: Scatolini M; Patel A; Grosso E; Mello-Grand M; Ostano P; Coppo R; Vitiello M; Venesio T; Zaccagna A; Pisacane A et al.
Source: Self-asserted source
Laura Poliseno via Europe PubMed Central

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma.

Journal of visualized experiments : JoVE
2021-09 | Journal article
Contributors: Vitiello M; Kusmic C; Faita F; Poliseno L
Source: Self-asserted source
Laura Poliseno via Europe PubMed Central

The Non-Coding RNA Journal Club: Highlights on Recent Papers—9

Non-Coding RNA
2021-09-16 | Review
Part of ISSN: 2311-553X
Contributors: Neil Renwick; Assam El-Osta; Irene Salamon; Elisabetta Broseghini; Manuela Ferracin; Laura Poliseno; Stanislovas Jankauskas; Gaetano Santulli; Hua Xiao; Patrick K. T. Shiu et al.
Source: Self-asserted source
Laura Poliseno

A eutherian-specific microRNA controls the translation of Satb2 in a model of cortical differentiation.

Stem cell reports
2021-05 | Journal article
Contributors: Martins M; Galfrè S; Terrigno M; Pandolfini L; Appolloni I; Dunville K; Marranci A; Rizzo M; Mercatanti A; Poliseno L et al.
Source: Self-asserted source
Laura Poliseno via Europe PubMed Central

Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System.

Thyroid : official journal of the American Thyroid Association
2021-03 | Journal article
Contributors: Corrado A; Aceto R; Silvestri R; Dell'Anno I; Ricci B; Miglietta S; Romei C; Giovannoni R; Poliseno L; Evangelista M et al.
Source: Self-asserted source
Laura Poliseno via Europe PubMed Central

Inducible modulation of miR-204 levels in a zebrafish melanoma model

Biology Open
2020-11-15 | Journal article
Contributors: Samanta Sarti; Raffaella De Paolo; Chiara Ippolito; Angela Pucci; Letizia Pitto; Laura Poliseno
Source: check_circle
Crossref

An Eutherian-Specific microRNA Controls the Translation of<i>Satb2</i>in a Model of Cortical Differentiation

2020-10 | Preprint
Contributors: Martins M; Galfrè S; Terrigno M; Pandolfini L; Appolloni I; Dunville K; Marranci A; Rizzo M; Mercatanti A; Poliseno L et al.
Source: Self-asserted source
Laura Poliseno via Europe PubMed Central

Proteomics pipeline for phosphoenrichment and its application on a human melanoma cell model.

Talanta
2020-07 | Journal article
Contributors: Finamore F; Ucciferri N; Signore G; Cecchettini A; Ceccherini E; Vitiello M; Poliseno L; Rocchiccioli S
Source: Self-asserted source
Laura Poliseno via Europe PubMed Central

PTENP1 is a ceRNA for PTEN: it's CRISPR clear.

Journal of hematology & oncology
2020-06-09 | Journal article
Source: Self-asserted source
Laura Poliseno
grade
Preferred source (of 2)‎

Biosafety and Biokinetics of Noble Metals: The Impact of Their Chemical Nature

ACS Applied Bio Materials
2019-10-21 | Journal article
Part of ISSN: 2576-6422
Part of ISSN: 2576-6422
Contributors: Domenico Cassano; Ana-Katrina Mapanao; Maria Summa; Ylea Vlamidis; Giulia Giannone; Melissa Santi; Elena Guzzolino; Letizia Pitto; Laura Poliseno; Rosalia Bertorelli et al.
Source: Self-asserted source
Laura Poliseno

476 GJB5 association with BRAF mutation and survival in cutaneous melanoma

Journal of Investigative Dermatology
2019-09 | Conference abstract
Part of ISSN: 0022-202X
Contributors: M. Scatolini; E. Grosso; M. Mello-Grand; P. Ostano; R. Coppo; A. Patel; M. Vitiello; T. Venesio; A. Zaccagna; A. Pisacane et al.
Source: Self-asserted source
Laura Poliseno

Systematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNA.

RNA biology
2019-04-19 | Journal article
Source: Self-asserted source
Laura Poliseno

MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response.

Biochimica et biophysica acta. Molecular basis of disease
2019-04-18 | Journal article
Source: Self-asserted source
Laura Poliseno

Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma.

Oncogene
2019-01 | Journal article
Contributors: Vitiello M; Evangelista M; Di Lascio N; Kusmic C; Massa A; Orso F; Sarti S; Marranci A; Rodzik K; Germelli L et al.
Source: Self-asserted source
Laura Poliseno via Europe PubMed Central

Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib.

The pharmacogenomics journal
2019-01 | Journal article
Contributors: Schirripa M; Borelli B; D'Aurizio R; Lubrano S; Cremolini C; Zucchelli G; Antoniotti C; Marmorino F; Prete AA; Murgioni S et al.
Source: Self-asserted source
Laura Poliseno via Europe PubMed Central

Development of a yeast-based system to identify new hBRAFV600E functional interactors

Oncogene
2018 | Journal article
EID:

2-s2.0-85053505935

Contributors: Lubrano, S.; Comelli, L.; Piccirilli, C.; Marranci, A.; Dapporto, F.; Tantillo, E.; Gemignani, F.; Gutkind, J.S.; Salvetti, A.; Chiorino, G. et al.
Source: Self-asserted source
Laura Poliseno via Scopus - Elsevier

Biological role of miR-204 and miR-211 in melanoma

Oncoscience
2018-08-22 | Journal article
Source: Self-asserted source
Laura Poliseno

Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells

Oncotarget
2017 | Journal article
EID:

2-s2.0-85017567482

Contributors: Vitiello, M.; Tuccoli, A.; D'Aurizio, R.; Sarti, S.; Giannecchini, L.; Lubrano, S.; Marranci, A.; Evangelista, M.; Peppicelli, S.; Ippolito, C. et al.
Source: Self-asserted source
Laura Poliseno via Scopus - Elsevier

The landscape of BRAF transcript and protein variants in human cancer

Molecular Cancer
2017 | Journal article
EID:

2-s2.0-85018436573

Contributors: Marranci, A.; Jiang, Z.; Vitiello, M.; Guzzolino, E.; Comelli, L.; Sarti, S.; Lubrano, S.; Franchin, C.; Echevarría-Vargas, I.; Tuccoli, A. et al.
Source: Self-asserted source
Laura Poliseno via Scopus - Elsevier

Ensemble Modeling Approach Targeting Heterogeneous RNA-Seq data: Application to Melanoma Pseudogenes

Scientific Reports
2017-12-11 | Journal article
Part of ISSN: 2045-2322
Contributors: Enrico Capobianco; Camilo Valdes; Samanta Sarti; Zhijie Jiang; Laura Poliseno; Nicolas F. Tsinoremas
Source: Self-asserted source
Laura Poliseno

Abstract LB-282: Two different strategies of delivery CRISPR/Cas9 system to gene edit rs4644 SNP in <i>LGALS3</i> gene

Cancer Research
2017-07-01 | Conference abstract
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Contributors: Alda Corrado; Irene Lepori; Simona Miglietta; Simone Batoni; Marianna Vitiello; Monica Evangelista; Elisa Chisci; Roberto Giovannoni; Laura Poliseno; Federica Gemignani et al.
Source: Self-asserted source
Laura Poliseno

Methods for the Identification of PTEN-Targeting MicroRNAs

PTEN
2016 | Book chapter
Part of ISBN: 9781493932979
Part of ISBN: 9781493932993
Part of ISSN: 1064-3745
Part of ISSN: 1940-6029
Contributors: Andrea Tuccoli; Marianna Vitiello; Andrea Marranci; Francesco Russo; Laura Poliseno
Source: Self-asserted source
Laura Poliseno

Alkaline phosphatase-positive immortal mouse embryo fibroblasts are cells in a transitional reprogramming state induced to face environmental stresses

Genetics and Epigenetics
2015 | Journal article
EID:

2-s2.0-84982747151

Contributors: Evangelista, M.; El Baroudi, M.; Rizzo, M.; Tuccoli, A.; Poliseno, L.; Pellegrini, M.; Rainaldi, G.
Source: Self-asserted source
Laura Poliseno via Scopus - Elsevier
grade
Preferred source (of 2)‎

Identification of BRAF 3'UTR isoforms in melanoma

Journal of Investigative Dermatology
2015 | Journal article
EID:

2-s2.0-84938087508

Contributors: Marranci, A.; Tuccoli, A.; Vitiello, M.; Mercoledi, E.; Sarti, S.; Lubrano, S.; Evangelista, M.; Fogli, A.; Valdes, C.; Russo, F. et al.
Source: Self-asserted source
Laura Poliseno via Scopus - Elsevier
grade
Preferred source (of 2)‎

Role of the oncogenic BRAFV600E in the osmostress response of yeast Saccharomyces cerevisiae

2015 | Conference abstract
Part of ISSN: 0749-503X
Contributors: Laura Poliseno
Source: Self-asserted source
Laura Poliseno

Suppression of CHK1 by ETS family members promotes DNA damage response bypass and tumorigenesis

Cancer Discovery
2015 | Journal article
EID:

2-s2.0-84975795249

Contributors: Lunardi, A.; Varmeh, S.; Chen, M.; Taulli, R.; Guarnerio, J.; Ala, U.; Seitzer, N.; Ishikawa, T.; Carver, B.S.; Hobbs, R.M. et al.
Source: Self-asserted source
Laura Poliseno via Scopus - Elsevier
grade
Preferred source (of 2)‎

Pseudogenes in Human Cancer

Frontiers in Medicine
2015-09-25 | Review
Part of ISSN: 2296-858X
Contributors: Laura Poliseno; Andrea Marranci; Pier Paolo Pandolfi
Source: Self-asserted source
Laura Poliseno

P-198 Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib

Annals of Oncology
2015-06 | Conference abstract
Part of ISSN: 0923-7534
Contributors: M. Schirripa; F. Loupakis; C. Cremolini; L. Poliseno; L. Salvatore; A. Tuccoli; C. Antoniotti; R. D'Aurzio; F. Marmorino; B. Borelli et al.
Source: Self-asserted source
Laura Poliseno

PTEN ceRNA networks in human cancer

Methods
2015-05 | Review
Part of ISSN: 1046-2023
Contributors: Laura Poliseno; Pier Paolo Pandolfi
Source: Self-asserted source
Laura Poliseno

Long non-coding RNAs in cancer: implications for personalized therapy

Cellular Oncology
2015-02 | Review
Part of ISSN: 2211-3428
Part of ISSN: 2211-3436
Contributors: Marianna Vitiello; Andrea Tuccoli; Laura Poliseno
Source: Self-asserted source
Laura Poliseno

Pseudogenes

Springer New York
2014 | Book
Part of ISSN: 1064-3745
Part of ISSN: 1940-6029
Source: Self-asserted source
Laura Poliseno

Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo

Pharmaceuticals
2013 | Journal article
EID:

2-s2.0-84887456935

Contributors: O'Reilly, K.E.; de Miera, E.V.-S.; Segura, M.F.; Friedman, E.; Poliseno, L.; Han, S.W.; Zhong, J.; Zavadil, J.; Pavlick, A.; Hernando, E. et al.
Source: Self-asserted source
Laura Poliseno via Scopus - Elsevier
grade
Preferred source (of 2)‎

MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling

Cell
2013 | Journal article
EID:

2-s2.0-84880570961

Source: Self-asserted source
Laura Poliseno
grade
Preferred source (of 3)‎
Items per page:
Page 1 of 2

Peer review (4 reviews for 4 publications/grants)

Review activity for Cancers. (1)
Review activity for Cell chemical biology. (1)
Review activity for Journal of experimental & clinical cancer research. (1)
Review activity for Journal of hematology & oncology. (1)